Nasal Bleeding Recruiting Phase 4 Trials for Bevacizumab (DB00112)

Also known as: Nosebleed (Epistaxis) - Posterior or Anterior / Nosebleed / Epistaxis Nosebleed / Nose bleed / Nosebleeds / Nose Bleeds / Epistaxis / Haemorrhage nasal / Bleeding from nose / Hemorrhage nasal / Hemorrhage from nose / Bleeding nose

IndicationStatusPhase
DBCOND0076797 (Nasal Bleeding)Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02389959Intranasal Bevacizumab for HHT-Related EpistaxisTreatment